Spectral Medical Inc. (OTCMKTS:EDTXF) Short Interest Up 7.9% in September

Spectral Medical Inc. (OTCMKTS:EDTXF) was the recipient of a large increase in short interest in the month of September. As of September 30th, there was short interest totalling 100,000 shares, an increase of 7.9% from the September 15th total of 92,700 shares. Based on an average trading volume of 35,900 shares, the short-interest ratio is currently 2.8 days.

Spectral Medical Stock Performance

Shares of OTCMKTS EDTXF opened at $0.42 on Wednesday. Spectral Medical has a 52 week low of $0.22 and a 52 week high of $0.55. The stock’s fifty day moving average is $0.47 and its 200 day moving average is $0.40. The stock has a market capitalization of $116.92 million, a P/E ratio of -8.34 and a beta of 0.93.

Spectral Medical (OTCMKTS:EDTXF) last released its earnings results on Friday, August 9th. The company reported ($0.01) EPS for the quarter. The business had revenue of $0.34 million for the quarter.

Spectral Medical Company Profile

Spectral Medical Inc focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, and internationally. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream.